ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1204

Understanding Community Perspectives on Disease Management: A Social Media Analysis of Gout Care Strategies

Maurice Flurie1, Monica Converse1, Christopher Parker2, Brian LaMoreaux3, Daniel Hernandez4, N. Lawrence Edwards5, Gary Ho1, Kristina Davidson6, E. Robert Wassman1, Christopher DeFelice1 and Maria Picone1, 1TREND Community, Philadelphia, PA, 2TREND Community, Austin, TX, 3Horizon Therapeutics, Deerfield, IL, 4Global Healthy Living Foundation, St. Johns, FL, 5University of Florida College of Medicine, Gainesville, FL, 6Horizon Therapeutics, Dublin, Ireland

Meeting: ACR Convergence 2023

Keywords: gout, Patient reported outcomes, Uric Acid, Urate

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1200–1220) Patient Outcomes, Preferences, & Attitudes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: To comprehensively understand the impact of disease management strategies, it is essential to understand the patient perspective. Gout is a chronic inflammatory arthritis characterized by painful joint flare-ups secondary to uric acid accumulation. Virtually all subspecialty groups recommend a proactive “treat-to-target” strategy to reduce serum urate levels, but many individuals living with gout adhere to a “treat-to-no symptoms” strategy. Here, we aimed to characterize gout community perspectives on various management approaches to gout care.

Methods: We evaluated 2 online social media communities using a proprietary analytics engine that evaluates social media conversations using natural language processing. Sources included a private Facebook group, The Gout Support Group of America (15,000+ members), which had 50,000 posts/comments from 2021 to 2023; and a public subreddit, r/gout (9,000+ members), with 125,000 posts/comments from 2011 to 2023. The engine used a topic modeling approach to identify the most frequent conversation themes across groups. Topics related to disease management were then tagged. All management topics were subject to sentiment analysis in which posts/comments were scored from −1 (most negative) to 1 (most positive) using a pretrained sentiment tagger. A final exploratory analysis identified the number of questions in each topic.

Results: Topic modeling yielded more than 30 topics that had at least 300 total posts/comments. Fourteen topics related to disease management (others related to disease burden, etc.). Polarity analysis showed the most positive management topics, in rank order, to be uric acid monitoring, weight loss, cbd/thc, allopurinol, and prednisone. Statistically significant differences were found between topic polarities as determined by 1-way ANOVA [F(4,10543) = 16.74, P = .0001]. A Tukey post hoc test revealed that uric acid monitoring conversation polarity was significantly higher [0.15 (0.24), P = .008] than cbd/thc conversations, as well as allopurinol and prednisone conversations but not weight loss conversations. Exploratory analysis showed that about 40% of all posts/comments in diseasemanagement topics included questions, compared with 20% in disease burden topics.

Conclusion: Using a proprietary analytics engine, we identified the most prevalent topics of conversation across 2 online gout communities. In comparing the top 5 most positive management topics, uric acid monitoring achieved the highest mean sentiment. Though the functional impact of sentiment differences is not easily appraised, these contrasts could suggest that gout community members tend to prefer uric acid monitoring over reactive management approaches such as prednisone. Disease management topics were composed of about 40% questions (vs 20% for disease burden topics), suggesting that increased awareness of various management strategies could benefit community members. Further work is needed to continue investigation of the patient perspective on gout management, which could be an important factor for patients having greater autonomy and participation in controlling their disease.


Disclosures: M. Flurie: TREND Community, 3, 12, Shareholder; M. Converse: TREND Community, 3, 12, Shareholder; C. Parker: Gout Support Group of America, 6, 12, Co-founder; B. LaMoreaux: Horizon Therapeutics, 3, 12, Stockholder; D. Hernandez: Global Healthy Living Foundation, 3; N. Edwards: Horizon Therapeutics, 2, United Rheumatology, 12, Medical Policy Committee Member; G. Ho: Gout Support Group of America, 1, 5, 8, 12, Grant funded from Horizon Therapeutics, plc, TREND Community, 3, 12, Shareholder; K. Davidson: Horizon Therapeutics, 3, 12, Stockholder; E. Wassman: TREND Community, 3, 12, Shareholder; C. DeFelice: TREND Community, 3, 12, Shareholder; M. Picone: TREND Community, 3, 12, Shareholder.

To cite this abstract in AMA style:

Flurie M, Converse M, Parker C, LaMoreaux B, Hernandez D, Edwards N, Ho G, Davidson K, Wassman E, DeFelice C, Picone M. Understanding Community Perspectives on Disease Management: A Social Media Analysis of Gout Care Strategies [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/understanding-community-perspectives-on-disease-management-a-social-media-analysis-of-gout-care-strategies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/understanding-community-perspectives-on-disease-management-a-social-media-analysis-of-gout-care-strategies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology